Loading chat...
CA AB2095
Bill
Status
Failed
11/30/2016
Primary Sponsor
Travis Allen
Click for details
AI Summary
- Requires the Legislative Analyst's Office to conduct a study comparing brand name prescription medications to biosimilars purchased or administered through the Medi-Cal program
- Study must cover the 2013-14 and 2014-15 fiscal years and be completed by January 1, 2018
- Study shall break down information by age, ethnicity, and gender of Medi-Cal recipients who received these medications
- No state funding appropriation required for the study
- Fiscal committee review is required
Legislative Description
Medi-Cal: prescriptions.
Last Action
From committee without further action.
11/30/2016
Committee Referrals
Health3/17/2016
Full Bill Text
No bill text available